On June 19, 2019, the US Senate Committee on Health, Education, Labor & Pensions (HELP) released its updated Lower Health Care Costs Act (S. 1895). This new version includes several noteworthy changes.
This Week’s Dose: Drug pricing remains in the spotlight, but lawmakers also introduced legislation focused on surprise billing and coinsurance.
Let me count the ways to 100. 1. Affordable Care Act. 2. Insurance Expansion. 3. Drug Pricing. 4. Surprise Billing. 5… Ok, maybe let me count to four.
McDermottPlus persuaded the Centers for Medicare and Medicaid Services (CMS) to revise Medicare laboratory “Date of Service” regulations.
Codes currently eligible for exception to DOS rule
McDermottPlus assessed the policy pathway and operational feasibility to scale up group prenatal care, and designed alternative payment models to facilitate implementation.
States that already have the CenteringPregnancy model of Group Prenatal Care
On behalf of a coalition of leading global manufacturers of blood glucose monitoring systems, McDermottPlus successfully advanced legislation intended to improve market access and patient choice under the Medicare Competitive Bidding Program.
Reduction in Medicare payment amount for diabetes test strips since 2012
Join McDermottPlus and McDermott Will & Emery as the discuss and analyze the long-awaited CMS draft guidance addressing the use of shared space, staff and services by hospitals and other enrolled providers.read more
McDermottPlus and McDermott Will & Emery invite you to join us on Thursday, June 27, 2019 at 8:45 AM for a breakfast discussion on hot topics in Medicare Advantage.read more
Dedicated resource libraries for clients and partner organizations.
A library of content about Medicare payment transformation initiatives. Includes original analysis, major regulations, agency guidance, program announcements and other primary source documents.
A collection of primary source materials about laboratory diagnostics regulation and payment, including original analysis, Medicare rates, rulemakings, final determinations and other items of interest.
A collection of materials about prescription drug pricing initiatives and regulation from the Administration and Congress, original analysis, and other items of interest.
A library of content about efforts to redesign health care insurance and coverage. Includes original analysis, major regulations, agency guidance, program announcements and other primary source documents.
Advises clients on reimbursement and policy strategy.
Advises clients on reimbursement policy strategy.
A board certified internal medicine physician and lawyer who is recognized as a Medicare law and policy authority.
A recognized Medicare law and policy authority and registered lobbyist.
Analyzes quantitative data and evaluates the economic impact.
A highly experienced Medicare veteran and former CMS director.
An accomplished health care executive with a deep understanding of federal health care law and policy.
A highly experienced government relations and legislative affairs strategist and advocate.
An accomplished health care executive with more than two decades on the Hill specializing in rural health, the health care safety net and disability policy.
An experienced government relations strategist who helps clients navigate the complex issues surrounding Medicare, Medicaid and the healthcare marketplace.
A government relations professional and registered lobbyist who supports clients on a range of health policy issues.